Zobrazeno 1 - 10
of 10
pro vyhledávání: '"S S, Klioze"'
Publikováno v:
Obesity Science & Practice. 2:256-265
SummaryObjective High-attrition rates have been observed in long-term clinical trials of weight loss agents. We evaluated the impact of an innovative retention programme on 1-year retention. Methods Three Phase 3 global multicentre clinical trials ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc6cb58ef351a07247a68f3a189f090c
https://doi.org/10.1002/osp4.57
https://doi.org/10.1002/osp4.57
Publikováno v:
Chemischer Informationsdienst. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f90d8ae8e21ec37f8ab91753ec4ec53
https://doi.org/10.1002/chin.198521260
https://doi.org/10.1002/chin.198521260
Autor:
V J, Bauer, B J, Duffy, D, Hoffman, S S, Klioze, R W, Kosley, A R, McFadden, L L, Martin, H H, Ong
Publikováno v:
Journal of medicinal chemistry. 19(11)
Synthesis of 1'-methyl-3-phenylspiro[isobenzofuran-1(3H),4'-piperidine] (7a, HP 365) and the demethyl analogue 9a (HP 505) was prompted by recognition of an aminoalkyl(aryl)isobenzofuran moiety common to the antidepressants talopram (Lu 3-010) and tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::26bb5c27b8de2fb9a320686ce1dfbdb9
https://pubmed.ncbi.nlm.nih.gov/1003409
https://pubmed.ncbi.nlm.nih.gov/1003409
Autor:
C A, Presant, M S, Soloway, S S, Klioze, A, Yakabow, S N, Presant, R G, Mendez, P S, Kennedy, M R, Wyres, V L, Naessig, B, Todd
Publikováno v:
Cancer. 59(10)
The safety and efficacy of buserelin, a luteinizing hormone-releasing hormone (LH-RH) agonist, was tested in 33 evaluable patients with Stages C or D adenocarcinoma of the prostate. With a minimum follow-up duration of 10 months, there was one comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47ea6b611ea826211acae682df37a75a
https://pubmed.ncbi.nlm.nih.gov/3103904
https://pubmed.ncbi.nlm.nih.gov/3103904
Autor:
C A, Presant, M S, Soloway, S S, Klioze, J W, Kosola, A L, Yakabow, R G, Mendez, P S, Kennedy, M R, Wyres, V L, Naessig, K S, Ford
Publikováno v:
Cancer. 56(10)
The effectiveness of buserelin, a luteinizing hormone-releasing hormone agonist, was tested in 28 patients with Stages C or D adenocarcinoma of the prostate. Of 24 evaluable patients, there were 13 partial responses (54%) by National Prostatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07c5eac30d5fa03ab672dacbd707cdbd
https://pubmed.ncbi.nlm.nih.gov/3930064
https://pubmed.ncbi.nlm.nih.gov/3930064
Publikováno v:
American journal of clinical oncology. 11
This multicenter, randomized study compared the LH-RH agonist buserelin with diethylstilbestrol (DES)/orchiectomy in the treatment of patients with stage D2 prostatic carcinoma. Subjects were randomized to treatment with buserelin or DES/orchiectomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f49b779e4e51cb7a45c847939c7837
https://pubmed.ncbi.nlm.nih.gov/3149455
https://pubmed.ncbi.nlm.nih.gov/3149455
Publikováno v:
European Journal of Cancer and Clinical Oncology. 23:1242
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e024c1b20dd16249226785e12d158923
https://doi.org/10.1016/0277-5379(87)90208-2
https://doi.org/10.1016/0277-5379(87)90208-2
Publikováno v:
Acta endocrinologica. Supplementum [Acta Endocrinol Suppl (Copenh)] 1984; Vol. 265, pp. 22-3.
Publikováno v:
Journal of steroid biochemistry [J Steroid Biochem] 1983 Jul; Vol. 19 (1C), pp. 995-8.
Autor:
Scott IA, Georgopapadakou N, Ho KS, Klioze S, Lee E, Lee SL Temme GH, Townsend CA, Armitage IM
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 1975 Apr 30; Vol. 97 (9), pp. 2548-50.